Literature DB >> 2935747

Huntington's disease in Venezuela: neurologic features and functional decline.

A B Young, I Shoulson, J B Penney, S Starosta-Rubinstein, F Gomez, H Travers, M A Ramos-Arroyo, S R Snodgrass, E Bonilla, H Moreno.   

Abstract

We studied 65 Huntington's disease patients and 225 at-risk individuals over the past 4 years. The rate of decline of these untreated patients from Venezuela was similar to that seen in US patients who had received neuroleptic drugs. Chorea, oculomotor dysfunction, and dysdiadochokinesis were early symptoms; parkinsonian features and dystonia came later. Juvenile patients declined nearly twice as fast as adult-onset patients. No distinctive neurologic phenotypes were seen in children of two affected parents.

Entities:  

Mesh:

Year:  1986        PMID: 2935747     DOI: 10.1212/wnl.36.2.244

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  Dopamine D2 receptor binding is reduced in Wilson's disease: correlation of neurological deficits with striatal 123I-iodobenzamide binding.

Authors:  W Oder; T Brücke; H Kollegger; J Spatt; S Asenbaum; L Deecke
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Parkinson's disease.

Authors:  N P Quinn; F A Husain
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-09

3.  Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Melissa J Armstrong; Janis M Miyasaki
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

4.  Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.

Authors:  Elisabeth A de Blieck; Erika F Augustine; Frederick J Marshall; Heather Adams; Jennifer Cialone; Leon Dure; Jennifer M Kwon; Nicole Newhouse; Katherine Rose; Paul G Rothberg; Amy Vierhile; Jonathan W Mink
Journal:  Contemp Clin Trials       Date:  2013-04-26       Impact factor: 2.226

Review 5.  Choosing an animal model for the study of Huntington's disease.

Authors:  Mahmoud A Pouladi; A Jennifer Morton; Michael R Hayden
Journal:  Nat Rev Neurosci       Date:  2013-10       Impact factor: 34.870

6.  Trinucleotide repeat length and progression of illness in Huntington's disease.

Authors:  K Kieburtz; M MacDonald; C Shih; A Feigin; K Steinberg; K Bordwell; C Zimmerman; J Srinidhi; J Sotack; J Gusella
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

7.  The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease.

Authors:  Jirí Klempír; Olga Klempírová; Jan Stochl; Natasa Spacková; Jan Roth
Journal:  J Neurol       Date:  2009-05-16       Impact factor: 4.849

8.  Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation.

Authors:  Irene Paradisi; Alba Hernández; Sergio Arias
Journal:  J Hum Genet       Date:  2007-12-22       Impact factor: 3.172

9.  Parallel explicit and implicit control of reaching.

Authors:  Pietro Mazzoni; Nancy S Wexler
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

10.  Dysphagia in Huntington's disease: a 16-year retrospective.

Authors:  M C Kagel; N A Leopold
Journal:  Dysphagia       Date:  1992       Impact factor: 3.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.